GCT
ZBH icon

Galaxy Capital Trading’s Zimmer Biomet ZBH Stock Holding History

Galaxy Capital Trading’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,635
Closed -$337K – 279
2013
Q2 		$337K Buy
+4,635
New +$347K 0.29% 110

Other funds holding ZBH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Galaxy Capital Trading's ZBH Position: Q3 2013 in Review

Galaxy Capital Trading sold out of Zimmer Biomet (ZBH) in Q3 2013, closing a stake of 4,635 shares — an estimated $337K sold.

Galaxy Capital Trading first reported a position in ZBH in Q2 2013 and held it in 1 quarter. The position peaked at $337K in Q2 2013. 650 funds tracked by Wall St. Rank hold ZBH as of Q3 2013.

  • Galaxy Capital Trading reported no remaining Zimmer Biomet position as of Q3 2013 after selling out during the quarter.
  • Galaxy Capital Trading sold 4,635 Zimmer Biomet shares in Q3 2013, an estimated $337K.
  • Galaxy Capital Trading first reported a position in Zimmer Biomet in Q2 2013 and held it in 1 quarter.
  • Galaxy Capital Trading's Zimmer Biomet position peaked at $337K in Q2 2013.
  • 650 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2013.

Based on Galaxy Capital Trading's 13F filing for Q3 2013, filed 4 Oct 2013.